Pakistan · Delayed Price · Currency is PKR Sitara Peroxide Statistics
Total Valuation
Sitara Peroxide has a market cap or net worth of PKR 2.73 billion. The enterprise value is 3.21 billion.
| Market Cap | 2.73B |
| Enterprise Value | 3.21B |
Important Dates
The last earnings date was Tuesday, January 27, 2026.
| Earnings Date | Jan 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sitara Peroxide has 55.10 million shares outstanding. The number of shares has decreased by -0.18% in one year.
| Current Share Class | 55.10M |
| Shares Outstanding | 55.10M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 61.39% |
| Owned by Institutions (%) | n/a |
| Float | 17.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.90 |
| P/TBV Ratio | 2.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 9,264.99 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.93 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31, with a Debt / Equity ratio of 0.52.
| Current Ratio | 0.31 |
| Quick Ratio | 0.05 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -76.12 |
Financial Efficiency
Return on equity (ROE) is -19.35% and return on invested capital (ROIC) is -20.78%.
| Return on Equity (ROE) | -19.35% |
| Return on Assets (ROA) | -6.52% |
| Return on Invested Capital (ROIC) | -20.78% |
| Return on Capital Employed (ROCE) | -25.35% |
| Weighted Average Cost of Capital (WACC) | 1.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -15.48M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -90.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +295.76% in the last 52 weeks. The beta is -0.52, so Sitara Peroxide's price volatility has been lower than the market average.
| Beta (5Y) | -0.52 |
| 52-Week Price Change | +295.76% |
| 50-Day Moving Average | 65.57 |
| 200-Day Moving Average | 35.08 |
| Relative Strength Index (RSI) | 28.84 |
| Average Volume (20 Days) | 20,685 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | 53.83M |
| Operating Income | -300.29M |
| Pretax Income | -291.30M |
| Net Income | -201.29M |
| EBITDA | -121.33M |
| EBIT | -300.29M |
| Earnings Per Share (EPS) | -3.66 |
Balance Sheet
The company has 5.87 million in cash and 483.96 million in debt, with a net cash position of -478.09 million or -8.68 per share.
| Cash & Cash Equivalents | 5.87M |
| Total Debt | 483.96M |
| Net Cash | -478.09M |
| Net Cash Per Share | -8.68 |
| Equity (Book Value) | 939.53M |
| Book Value Per Share | 17.07 |
| Working Capital | -1.08B |
Cash Flow
| Operating Cash Flow | 294,442 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sitara Peroxide does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.18% |
| Shareholder Yield | 0.18% |
| Earnings Yield | -7.38% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |